Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency.
Körholz J, Tromp SAM, Dalm VASH, de Bie M, de Bree GJ, van Leeuwen EMM, Fraaij PLA, Jansen MH, Hollink IHIM, Nagelkerke SQ, Russ S, Scholze AK, Soomann M, Wiedemuth R, Pachlopnik Schmid J, Hanitsch LG, Schuetz C, Kuijpers TW, IJspeert H. Körholz J, et al. Among authors: van leeuwen emm. J Allergy Clin Immunol. 2025 Aug;156(2):279-293. doi: 10.1016/j.jaci.2025.04.033. Epub 2025 May 20. J Allergy Clin Immunol. 2025. PMID: 40403933 Free article.
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Pothast CR, Hofsink Q, Haggenburg S, Dijkland RC, Van de Meent M, Van Dijk K, Bhoekhan MS, Haverkate NJE, Van Meerloo J, Falkenburg JHF, De Groen RAL, Broers AEC, Van Doesum JA, Van Binnendijk RS, Den Hartog G, Lissenberg-Witte BI, Kater AP, Smits GP, Wouters D, Van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Van Baarle D, De Vries RD, Van Meerten T, Mutsaers PGNJ, Goorhuis A, Nijhof IS, Hazenberg MD, Heemskerk MHM, Rutten CE, Study Team CK. Pothast CR, et al. Among authors: van leeuwen emm. Haematologica. 2025 Nov 1;110(11):2799-2805. doi: 10.3324/haematol.2024.287136. Epub 2025 May 29. Haematologica. 2025. PMID: 40438989 Free PMC article. No abstract available.
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections.
Nassar-Sheikh Rashid A, Bergkamp SC, Kampinga RE, Gouw SC, Bouts AHM, Oosterveld MJS, Baars PA, van Leeuwen EMM, Kuijpers TW, van den Berg JM, Schonenberg-Meinema D. Nassar-Sheikh Rashid A, et al. Among authors: van leeuwen emm. Clin Exp Rheumatol. 2023 Nov;41(11):2323-2330. doi: 10.55563/clinexprheumatol/yqjz1s. Epub 2023 Jul 13. Clin Exp Rheumatol. 2023. PMID: 37470239 Free article.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q, Haggenburg S, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, van Meerloo J, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Rots N, van Beek J, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI study team. Hofsink Q, et al. Among authors: van leeuwen emm. EClinicalMedicine. 2023 Jul;61:102040. doi: 10.1016/j.eclinm.2023.102040. Epub 2023 Jun 15. EClinicalMedicine. 2023. PMID: 37337616 Free PMC article.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI Study Team. Haggenburg S, et al. Among authors: van leeuwen emm. JAMA Oncol. 2022 Oct 1;8(10):1477-1483. doi: 10.1001/jamaoncol.2022.3227. JAMA Oncol. 2022. PMID: 35951338 Free PMC article.
65 results